Jubilant Life Sciences stocks settled 4.08 per cent up at Rs 367.35 after it received final approval from the US health regulator for generic Levetiracetam injection, used for treatment of epilepsy, in the American market.
The BSE Sensex and NSE Nifty ended lower on Monday as caution prevailed a day before Reserve Bank of India’s decision on policy rates and ahead of a number of global risk events this month, including a US Federal Reserve meeting. Sensex dropped 65.58 points to end at 26,777.45, while NSE Nifty fell 19.75 points to 8,201.05.
Below are the 5 stocks that hogged limelight in Monday’s trade
Steel Strips Wheels: Shares of the company closed 6.75 per cent up at Rs 441 on BSE after its promoter – Chandigarh Developers – increased its stake in the company via open market purchase.
Sun Pharma: Stocks of the company ended 1.67 per cent down at Rs 725.95 after it sold two of its US-based manufacturing facilities along with 15 products to Frontida BioPharm Inc for an undisclosed amount.
Biocon: Stocks of the company ended 3.29 per cent up at Rs 726.20 after Mylan Inc and Biocon confirmed the efficacy and safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the firms, in comparison to Roche’s branded Herceptin used for treatment of cancer.
Jubilant Life Sciences: Stocks of the company settled 4.08 per cent up at Rs 367.35 after it received final approval from the US health regulator for generic Levetiracetam injection, used for treatment of epilepsy, in the American market.
Thyrocare Technologies: According to TV reports, Maharashtra Association of Resident doctors has alleged that the company is paying commission to resident doctors and said there is gross violation of ethics by the lab. It has written a letter to Maharashtra Medical Council. The company however has denied the allegation. Reacting to the news, stocks of the company ended 5.59 per cent down at Rs 595.55